Literature DB >> 14207786

THE FIBRINOLYTIC MECHANISM IN HAEMOSTASIS: A REVIEW.

J L STAFFORD.   

Abstract

Keywords:  BLOOD PLATELETS; FIBRIN; FIBRINOGEN; FIBRINOLYSIS; HEMOSTASIS; HYPERLIPEMIA; LIPID METABOLISM; LIPOPROTEINS; PLASMINOGEN; REVIEW; THROMBOSIS

Mesh：

Substances：

Year:  1964        PMID： 14207786      PMCID： PMC480808          DOI： 10.1136/jcp.17.5.520

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  94 in total

1.  Plasmin-antiplasmin complex as a reservoir of fibrinolytic enzyme.

Authors:  C M AMBRUS; G MARKUS
Journal:  Am J Physiol       Date:  1960-09

2.  Treatment of peripheral arterial occlusion by streptokinase perfusion.

Authors:  G P MCNICOL; W REID; W H BAIN; A S DOUGLAS
Journal:  Br Med J       Date:  1963-06-08

3.  Thrombolytic therapy.

Authors:  G P MCNICOL
Journal:  Proc R Soc Med       Date:  1963-05

4.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. III. Demonstration of abnormal clot structure by electron microscopy.

Authors:  N U BANG; A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

5.  Blood capillaries of the heart and other organs.

Authors:  G E PALADE
Journal:  Circulation       Date:  1961-08       Impact factor: 29.690

6.  Physical properties of highly purified human plasminogen.

Authors:  M C DAVIES; M E ENGLERT
Journal:  J Biol Chem       Date:  1960-04       Impact factor: 5.157

7.  Studies on the thrombolytic activity of human plasma.

Authors:  W D SAWYER; A P FLETCHER; N ALKJAERSIN; S SHERRY
Journal:  J Clin Invest       Date:  1960-02       Impact factor: 14.808

8.  A study of artificial thrombi produced by a modification of Chandler's method.

Authors:  J C POOLE
Journal:  Q J Exp Physiol Cogn Med Sci       Date:  1959-10

9.  On the production of plasma fibrinolytic activity within veins.

Authors:  H C KWAAN; R LO; A J MCFADZEAN
Journal:  Clin Sci       Date:  1957-05       Impact factor: 6.124

10.  Role of Hageman factor in the initiation of clotting by glass; evidence that glass frees Hageman factor from inhibition.

Authors:  O D RATNOFF; J M ROSENBLUM
Journal:  Am J Med       Date:  1958-08       Impact factor: 4.965
View more
  4 in total

1.  Rationale for the selective administration of tranexamic acid to inhibit fibrinolysis in the severely injured patient.

Authors:  Ernest E Moore; Hunter B Moore; Eduardo Gonzalez; Angela Sauaia; Anirban Banerjee; Christopher C Silliman
Journal:  Transfusion       Date:  2016-04       Impact factor: 3.157

2.  Fibrinolysis shutdown is associated with a fivefold increase in mortality in trauma patients lacking hypersensitivity to tissue plasminogen activator.

Authors:  Hunter B Moore; Ernest E Moore; Benjamin R Huebner; Monika Dzieciatkowska; Gregory R Stettler; Geoffrey R Nunns; Peter J Lawson; Arsen Ghasabyan; James Chandler; Anirban Banerjee; Christopher Silliman; Angela Sauaia; Kirk C Hansen
Journal:  J Trauma Acute Care Surg       Date:  2017-12       Impact factor: 3.313

3.  Targeting resuscitation to normalization of coagulating status: Hyper and hypocoagulability after severe injury are both associated with increased mortality.

Authors:  Hunter B Moore; Ernest E Moore; Ioannis N Liras; Charles Wade; Benjamin R Huebner; Clay Cothren Burlew; Fredric M Pieracci; Angela Sauaia; Bryan A Cotton
Journal:  Am J Surg       Date:  2017-09-18       Impact factor: 2.565

4.  Recombinant Destabilase from Hirudo medicinalis Is Able to Dissolve Human Blood Clots In Vitro.

Authors:  Pavel Bobrovsky; Valentin Manuvera; Izolda Baskova; Svetlana Nemirova; Alexandr Medvedev; Vassili Lazarev
Journal:  Curr Issues Mol Biol       Date:  2021-11-20       Impact factor: 2.976
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.